Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows revision: v3.6.6, replacing v3.6.5, indicating a minor update to the page's documentation or underlying system. This change does not modify study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:18.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This appears to be a minor platform/documentation update with no visible changes to the trial details or content.
    Difference
    0.1%
    Check dated 2026-08-08T17:03:51.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.4, replacing the previous v3.6.3, indicating a minor update to the study record page. This appears to be a backend or formatting update rather than changes to the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-25T08:27:12.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page revision label updated to v3.6.3, replacing v3.6.2. This reflects a minor internal update to the study page without altering visible content.
    Difference
    0.1%
    Check dated 2026-07-03T22:53:38.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.2, replacing the prior v3.6.0. This indicates a small update to the page template or underlying system without altering study details or data presented.
    Difference
    0.1%
    Check dated 2026-06-26T23:22:03.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The page now communicates that recruitment is closed and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with Intervention/Treatment; the site version updates to v3.6.0, and the older label 'Intervention / Treatment' and revision note v3.5.5 are removed.
    Difference
    0.4%
    Check dated 2026-06-12T17:31:24.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.